Norovirus vs Rotavirus: Key Differences

Norovirus vs rotavirus is a comparison most people make at 3 a.m. over a bathroom floor, and the answer matters more than it seems. Both viruses cause acute gastroenteritis, the combination of vomiting, diarrhea, and cramps that sweeps through households, schools, and cruise ships. They are unrelated organisms, though. They differ in who they sicken, how long they last, how they spread, and above all whether a vaccine exists. This article lays out those differences, with numbers from public-health agencies and peer-reviewed studies.

Educational content, not medical advice. Talk to your doctor before changing any medication, treatment, or routine. If a child or older adult shows signs of dehydration, contact a clinician promptly.

Two viruses, two designs

The simplest way to see the difference is to look at what each virus is made of. Both are RNA viruses without a fatty outer envelope, but the similarity ends there.

Norovirus belongs to the family Caliciviridae. Its genome is a single strand of RNA, roughly 7.5 kilobases long, that host ribosomes can read directly, so the virus does not need to carry its own copying enzyme into the cell before it starts. It has a single protein shell. Human strains are sorted into genogroups and genotypes, and a 2016 review in PLOS Medicine counted 29 human genotypes across genogroups GI (9), GII (19), and GIV (1) (Lopman et al., 2016).

Rotavirus belongs to Reoviridae. Its genome is double-stranded RNA split into 11 separate segments, packed inside three concentric protein shells like a set of nested dolls. The outer proteins VP7 (the "G" type) and VP4 (the "P" type) define the strain and trigger neutralizing antibodies. The CDC's Pink Book notes that G1 and G12 strains cause most infections (CDC Pink Book, Rotavirus). The segmented genome matters because when two strains infect the same cell, they can swap segments like cards from two shuffled decks, producing new combinations.

For readers new to the underlying mechanics, how viruses work from infection to replication covers the general cycle. For each virus in more depth, see the companion pieces on norovirus and rotavirus.

At-a-glance comparison

Feature	Norovirus	Rotavirus
Virus family	Caliciviridae	Reoviridae
Genome	Single-stranded RNA, ~7.5 kb	Double-stranded RNA, 11 segments
Main victims	All ages	Infants and young children
Incubation	12 to 48 hours	About 2 days
Typical duration	1 to 3 days	3 to 8 days of vomiting and watery diarrhea
Spread	Contact, food, surfaces, shellfish	Fecal-oral, close contact, surfaces
Shedding after recovery	2 weeks or more	Several days; more than 30 days if immunocompromised
Licensed vaccine	None	Two oral vaccines
Immunity after infection	Short-lived and strain-specific	Partial; later infections milder
Treatment	Rehydration; no antiviral	Rehydration; no antiviral

Sources for the incubation, duration, and shedding figures are the CDC pages on norovirus and rotavirus and the Pink Book chapter linked above.

Who gets sick

Norovirus: an equal-opportunity virus

Norovirus infects people of every age. Adults get it as readily as children, which is why outbreaks in nursing homes, cruise ships, military units, and restaurants are common news. Because immunity is short-lived and strain-specific, one infection does not reliably protect against the next. The GII.4 genotype, which dominates globally, produces new variants every two to four years, so the virus keeps escaping the immune memory built by earlier infections (Lopman et al., 2016).

Your genes also matter. For the prototype Norwalk strain (genotype GI.1), people who lack a functional FUT2 gene, called non-secretors, lack the sugar structure on gut cells that the virus uses as a docking point, and are largely resistant to that strain. Roughly 70 to 80% of people have a functional copy, which implies that about 20 to 30% are non-secretors. The protection is strain-dependent, though, and other norovirus strains can infect non-secretors, so being a non-secretor does not make anyone safe from norovirus in general.

Rotavirus: the childhood virus

Rotavirus is mainly a disease of infants and young children. The CDC notes that older children and adults, including people with weakened immune systems, can also get sick, but adults usually have milder symptoms (CDC). In the United States before vaccination, about 95% of children had been infected by age five, and rotavirus accounted for 30% to 50% of gastroenteritis hospitalizations in children under five (CDC Pink Book).

Natural infection does not give permanent protection, but it does build it step by step. In a cohort study in Mexico described in the Pink Book, one natural infection gave 38% protection against any later infection, 77% against diarrhea, and 87% against severe diarrhea, and each additional infection generally caused milder illness. The pattern explains why adults, who have been exposed many times, rarely get sick. It also explains why the first infection in a baby, with no prior immunity, is the dangerous one. The general machinery behind this is covered in how the immune system recognizes threats.

How the two spread

Norovirus: built to travel

A single infected person can seed an outbreak because the virus is efficient at every step. According to the CDC, you can catch it through direct contact with an infected person, by eating or drinking contaminated food or liquid, or by touching a contaminated surface and then your mouth. Raw or undercooked shellfish such as oysters can carry it too (CDC).

Dose-response modeling of human volunteer studies helps explain how easily it spreads. One analysis estimated that the average probability of infection from a single Norwalk virus particle is close to 0.5, and that the chance of becoming ill rises from about 0.1 at 1,000 genome copies to about 0.7 at 100 million (Teunis et al., 2008, Journal of Medical Virology). Those are model estimates from a small number of challenge experiments, and aggregation of virus particles complicates them, but the general message is robust: very small doses can infect, while a person with active illness can shed enormous amounts.

The other half of the story is how long infected people stay contagious. The CDC says you can still spread norovirus for two weeks or more after you feel better, and recommends staying home for 48 hours after symptoms stop (CDC). Someone who feels fine on day three may still be a source on day ten.

Rotavirus: the fecal-oral route and hardy particles

Rotavirus spreads primarily through the fecal-oral route, meaning virus from stool reaches another person's mouth through hands, toys, surfaces, or food. The Pink Book describes the particles as very stable, able to remain viable in the environment for weeks or months. Infected people shed virus from about two days before diarrhea begins and for several days after, and people with weakened immune systems may shed for more than 30 days.

Child-care centers are the classic setting because young children touch everything, put their hands in their mouths, and need help with diapers and toileting. The long pre-symptom shedding window explains why exclusion policies alone rarely stop spread: by the time a child is visibly ill, others have already been exposed.

Why alcohol hand sanitizer is a weak defense against norovirus

Many people reach for hand sanitizer during a stomach-bug outbreak, and the evidence says it is not the best choice for norovirus. The CDC advises washing with soap and water for at least 20 seconds and notes that hand sanitizer does not work well against norovirus. It can supplement washing but should not replace it (CDC prevention).

Laboratory work supports this. Human norovirus could not be grown reliably in the lab for decades, which blocked basic research and disinfectant testing. In 2016 a team at Baylor College of Medicine reported that multiple human norovirus strains could replicate in stem cell-derived human intestinal enteroid cultures when bile was present (Ettayebi et al., 2016, Science). Using that system, a later study tested disinfectants on GII.4 strains. A 70% ethanol solution reduced replication by up to 0.7 log10 (a roughly five-fold drop) but did not fully inactivate the virus, and isopropanol after five minutes produced no reduction. Chlorine at concentrations above 50 ppm did inactivate the tested strains in one-minute exposures, although the authors cautioned that stool-laden samples consume chlorine and the effective concentration needed in real settings is uncertain (Costantini et al., 2018, Emerging Infectious Diseases).

For cleaning up after someone has vomited or had diarrhea, the CDC recommends wearing gloves, cleaning promptly, and disinfecting with a chlorine bleach solution of 1,000 to 5,000 ppm (or an EPA-registered norovirus disinfectant), leaving it on the surface for at least five minutes. It also advises cooking oysters and other shellfish to an internal temperature of at least 145 degrees Fahrenheit (63 degrees Celsius), because quick steaming does not heat food enough to kill the virus (CDC prevention).

Symptoms and timeline

Both viruses cause nausea, vomiting, diarrhea, and stomach pain, and fever is possible with either, which is why symptoms alone rarely identify the culprit. The differences are in tempo and duration.

Norovirus symptoms usually begin 12 to 48 hours after exposure, and most people recover within one to three days, according to the CDC. Clinicians often describe an abrupt start with vomiting prominent, but the overlap with other causes of gastroenteritis is large.

Rotavirus symptoms usually begin about two days after exposure. The CDC says severe watery diarrhea, vomiting, fever, and stomach pain are most common, and vomiting and watery diarrhea can last three to eight days (CDC). Longer diarrhea means more fluid loss, and infants have small fluid reserves, which is why rotavirus is so much more dangerous for them than for a healthy adult.

Dehydration: the real danger

For both viruses, the main risk is dehydration, not the virus itself. The body loses water and salts faster than it can replace them, and the circulation and kidneys begin to struggle. The CDC lists signs including decreased urination, a dry mouth, dizziness when standing, and unusual sleepiness or fussiness in young children. The physiology of thirst and fluid balance is covered in how your body knows it is thirsty and how kidneys balance salt and water.

Seek medical care promptly if a baby, young child, or older adult shows these signs, if there is blood in the stool, or if symptoms are severe or prolonged. This article cannot tell you which situation applies to a particular person.

The scale of each virus worldwide

Both are among the leading causes of diarrheal illness, but they differ in the shape of their burden. Norovirus causes enormous numbers of mostly mild illnesses across all ages. Rotavirus causes fewer illnesses but a disproportionate share of deaths in young children, especially where care is limited.

Measure	Norovirus	Rotavirus
Global illnesses	About 684 million episodes per year (WHO foodborne estimates, 2010)	More than 258 million diarrhea episodes in children under 5 (2016)
Global deaths	About 212,000 per year (WHO, 2010), about 99% in middle- and high-mortality countries	About 128,500 deaths in children under 5 (2016)
Economic cost	About $60.3 billion per year in societal costs	Not compared here
US burden before vaccine	Not summarized here	About 2.7 million infections, 55,000 to 70,000 hospitalizations, and 20 to 60 deaths per year in children under 5

The norovirus figures come from a 2016 review in PLOS Medicine, which also found that about two-thirds of the economic burden falls on children under five (Lopman et al., 2016). The rotavirus figures come from a 2018 JAMA Pediatrics analysis, which found that rotavirus caused about 128,500 deaths in 2016 (uncertainty range 104,500 to 155,600), including about 104,700 in sub-Saharan Africa (Troeger et al., 2018), and from the Pink Book for the US numbers. The years, populations, and methods differ, so these are not a head-to-head ranking.

Both viruses also trace back to a long history of waterborne and fecal-oral disease. The famous example from the nineteenth century is John Snow and the Broad Street pump, which showed that contaminated water can drive an epidemic of diarrheal illness. Rotavirus itself was first seen in 1973, when Ruth Bishop and colleagues in Australia reported virus particles in the duodenal cells of children with acute non-bacterial gastroenteritis (Bishop et al., Lancet, 1973).

Seasonality

In temperate climates, rotavirus peaks in fall and winter and is less seasonal in tropical regions. The Pink Book notes that after vaccine introduction in the United States, a biennial pattern of activity emerged, with alternating years of higher and lower circulation. Norovirus is also weighted toward cooler months in many temperate countries, which gave it the nickname "winter vomiting bug," though outbreaks occur year-round because they depend on contact in crowded settings.

Vaccines: the biggest practical difference

Rotavirus: two oral vaccines with a strong record

Two vaccines are licensed in the United States, both given by mouth as drops. According to the CDC, RotaTeq is given in three doses at 2, 4, and 6 months of age, and Rotarix in two doses at 2 and 4 months. The first dose should be given before the child is 15 weeks old, and all doses should be completed before 8 months of age. The CDC says about 9 in 10 vaccinated infants are protected from severe rotavirus disease, about 7 in 10 from rotavirus disease of any severity, and 94% to 96% from hospitalization (CDC vaccine page).

Trial results in the Pink Book include 98% efficacy against severe disease in the first season for RotaTeq and, for Rotarix, 85% against severe disease to age one in Latin America. In US case-control studies, effectiveness against emergency visits or hospitalization was about 83% to 84%. Efficacy tends to be lower in low-income settings, a gap that vaccine researchers have studied for years, though the vaccines still prevent substantial disease there.

The vaccines also protect people who are not vaccinated. A 2018 meta-analysis found pooled indirect effectiveness against rotavirus hospitalization in children under five of 48%, higher in high-income countries (52%) than in low- and middle-income countries (25%) (Rosettie et al., 2018, American Journal of Tropical Medicine and Hygiene). At the population level, the JAMA Pediatrics analysis estimated that vaccination had averted more than 28,000 child deaths by 2016, and that expanding coverage could have prevented roughly 20% of under-five diarrhea deaths (Troeger et al., 2018).

The one real risk

Rotavirus vaccines carry a small risk of intussusception, a rare blockage where one segment of bowel telescopes into another. The CDC estimates about one extra case per 20,000 to 100,000 US infants, concentrated in the week after the first or second dose. Before rotavirus vaccine was used, about 1,900 US infants a year developed intussusception before age one. With prompt treatment almost all recover, though some need surgery, and warning signs include severe crying with stomach pain, pulling the legs up, repeated vomiting, or blood in the stool (CDC vaccine page). Parents weighing this should discuss it with a pediatrician.

Norovirus: no licensed vaccine yet

No norovirus vaccine is licensed. The obstacles are scientific. There are dozens of genotypes, new GII.4 variants appear every few years, immunity after infection fades, and until the 2016 enteroid breakthrough the virus could not be grown in standard laboratory cultures. Early vaccine candidates used virus-like particles, which are protein shells resembling the virus without its genome.

The most advanced candidate is a Moderna mRNA vaccine, mRNA-1403, in a phase 3 trial launched in September 2024 with a target enrollment of up to 20,000 adults aged 60 and older plus 5,000 adults aged 18 to 59. The trial faced a clinical hold after a single case of Guillain-Barré syndrome and trouble accumulating enough norovirus cases. In its second-quarter 2026 update, Moderna said the trial did not meet statistical criteria for early success but would continue, remaining blinded while more patients are enrolled (CIDRAP). It is not an answer yet.

For background on how immune memory is trained, see how vaccines work and the immune system explained.

Diagnosis and treatment

Doctors usually diagnose gastroenteritis from symptoms and context, because the tests rarely change management in healthy people. When laboratory confirmation matters, such as in outbreaks, hospital cases, or people with weakened immune systems, laboratories can detect either virus in stool using molecular or antigen tests.

There is no antiviral treatment for either infection, and antibiotics do not work against viruses. Treatment is supportive and centers on replacing lost fluid and salts, usually with an oral rehydration solution that contains a balanced mix of glucose and electrolytes, given in small, frequent amounts. Severe dehydration may need intravenous fluids in a medical setting.

Probiotics have been studied as an add-on for acute infectious diarrhea in general, not for norovirus or rotavirus specifically. A 2010 Cochrane review of 63 studies and 8,014 participants found that probiotics shortened mean diarrhea duration by about 24.8 hours, but the trials varied in quality and results differed widely between studies (Allen et al., 2010). The evidence supports a modest benefit at best, and strain, dose, and population matter.

Prevention at a glance

For norovirus, the CDC advice is to wash hands with soap and water, disinfect contaminated surfaces with a chlorine bleach solution, cook shellfish thoroughly, and avoid preparing food for others while ill and for 48 hours after symptoms end. These measures matter especially for people who work in restaurants, schools, child care, or long-term care.

For rotavirus, vaccination is the most effective step and the CDC calls it the best way to protect children. Handwashing and cleaning contaminated surfaces help, but because the virus is so stable in the environment and shed before symptoms, hygiene alone has not controlled it.

Common confusions

"It is all just the stomach flu." Influenza is a respiratory virus unrelated to either one, as explained in influenza virus explained. "Stomach flu" is a nickname for viral gastroenteritis, which is caused by several viruses, including norovirus, rotavirus, and others such as adenovirus.

"Hand sanitizer will protect me." For norovirus, soap and water is the better option, as described above.

"If I had it once, I am immune." Immunity to norovirus is short-lived and strain-specific. Rotavirus immunity builds with repeated infections, but the first infections are the severe ones.

"A fever means it is rotavirus." Fever occurs with either virus and with bacterial infections. Symptoms cannot distinguish them reliably.

"Any fever means an emergency." Fever is part of the immune response, which is explored in why fevers help fight infections. In infants, though, a high or lasting fever should still prompt a call to a clinician.

Frequently asked questions

Q: What is the main difference between norovirus and rotavirus? A: Norovirus infects all ages, causes a short illness of one to three days, and has no licensed vaccine. Rotavirus mainly affects infants and young children, causes vomiting and watery diarrhea lasting three to eight days, and is preventable with oral vaccines. Both are treated by replacing fluids, and neither responds to antibiotics.

Q: Which virus is more contagious? A: Norovirus is widely considered the more efficient spreader, because very small doses can cause infection, people shed it for two weeks or more after recovery, and it spreads through food, surfaces, and contact. Rotavirus is also highly contagious and survives for weeks or months in the environment.

Q: Can you get norovirus more than once? A: Yes. There are many genotypes, immunity after infection is short-lived and strain-specific, and new variants of the dominant GII.4 genotype appear every two to four years. People can be reinfected within months or years.

Q: Why is there a rotavirus vaccine but no norovirus vaccine? A: Rotavirus has a limited set of strains that dominate, a defined age group at greatest risk, and a long record of efficacy trials. Norovirus has many genotypes, fast-changing variants, and could not be cultured in the lab until 2016. An mRNA candidate is in phase 3 testing, but results are not final.

Q: How long is someone contagious? A: With norovirus, people can spread the virus for two weeks or more after recovery, and the CDC advises staying home for 48 hours after symptoms stop. With rotavirus, shedding starts about two days before diarrhea and continues for several days after symptoms resolve, and longer in people with weakened immune systems.

Q: Can adults get rotavirus? A: Yes. Adults, including those with weakened immune systems, can get sick, but illness is usually milder because most adults were infected as children and built partial immunity.

Q: When should I seek medical help? A: Contact a clinician promptly if a baby, child, or older adult shows dehydration signs such as decreased urination, a dry mouth, dizziness on standing, or unusual sleepiness, or if there is blood in the stool or symptoms are severe or prolonged. Infants have little fluid reserve, so earlier contact is wise.

The takeaway

Norovirus and rotavirus produce similar misery with different logic. Norovirus is the fast, indiscriminate traveler: tiny doses infect, shedding lasts for weeks, alcohol sanitizers fall short, and constantly changing variants have so far stayed ahead of vaccine makers. Rotavirus is the slower, more dangerous threat to babies, and it is also the one humanity has largely learned to blunt, with oral vaccines that prevent most severe disease and have averted thousands of deaths. The most practical lesson from comparing them is that the right response depends on the virus: soap, bleach, and a 48-hour stay-home rule for norovirus, and timely vaccination for rotavirus, with rehydration as the common ground.

Sources

• Lopman B, Steele D, Kirkwood CD, Parashar UD. "The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control." PLOS Medicine 2016. PMC4846155
• Centers for Disease Control and Prevention. Norovirus pages: About and Prevention.
• Centers for Disease Control and Prevention. Rotavirus pages: About and Vaccines.
• CDC. Pink Book, Chapter 19: Rotavirus. cdc.gov
• Troeger C et al. "Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 Years." JAMA Pediatrics 2018. Europe PMC
• Rosettie KL et al. "Indirect Rotavirus Vaccine Effectiveness for the Prevention of Rotavirus Hospitalization." Am J Trop Med Hyg 2018. Europe PMC
• Teunis PF et al. "Norwalk virus: how infectious is it?" J Med Virol 2008;80:1468-1476. Europe PMC
• Ettayebi K et al. "Replication of human noroviruses in stem cell-derived human enteroids." Science 2016. Europe PMC
• Costantini VP et al. Norovirus disinfectant testing in human intestinal enteroids. Emerg Infect Dis 2018. PMC6056096
• Allen SJ et al. "Probiotics for treating acute infectious diarrhoea." Cochrane Database Syst Rev 2010. Europe PMC
• Bishop RF et al. "Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis." Lancet 1973. Europe PMC
• CIDRAP. "No early success for Moderna's norovirus vaccine in phase 3 trial," August 2026. cidrap.umn.edu

---

Read next:

• Norovirus Explained: Why the Stomach Bug Is Almost Impossible to Stop
• How Vaccines Work: History and Science
• The Immune System: How It Works Explained